Skip to contentBaker Biotech Capital (GP), LLC — GENOMIC HEALTH INC insider: 246 transactions · InsiderLensBaker Biotech Capital (GP), LLC
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 28, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Feb 28, 2006
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- Director at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- Director at GENOMIC HEALTH INC · on record since Sep 11, 2006
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 30, 2006
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- Director at INCYTE CORP · on record since Aug 3, 2007
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- Director at NEUROGEN CORP · on record since Apr 15, 2008
- 10% owner at NEUROGEN CORP · on record since Apr 15, 2008
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- 10% owner at VAXGEN INC · on record since Jul 29, 2010
- 10% owner at PHARMACYCLICS INC · on record since Aug 24, 2011
- Director at TRIMERIS INC · on record since Nov 4, 2011
- 10% owner at TRIMERIS INC · on record since Nov 4, 2011
- 10% owner at TRANZYME INC · on record since Mar 14, 2012
- 10% owner at XOMA LTD /DE/ · on record since Mar 8, 2012
Insider trading activity of Baker Biotech Capital (GP), LLC
- Transactions on record
- 246
- since Sep 23, 2003
- Open-market buys
- 169
- $42.3M
- Open-market sells
- 41
- $24.7M
- Companies traded
- 13
- last filing Mar 14, 2012
Figures computed from official regulatory filings — methodology.
Companies where Baker Biotech Capital (GP), LLC has traded
Track record of Baker Biotech Capital (GP), LLC
Statistical track record
Free- Open-market buys
- 194
- Last buy
- Mar 14, 2012
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Baker Biotech Capital (GP), LLC
Co-insiders of Baker Biotech Capital (GP), LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
21 tx · $11.3K · Oct 21, 2008
BAKER BROS. ADVISORS LPBIOCRYST PHARMACEUTICALS INC +7
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 14, 2012 | Buy | 15,599 | 2.96 USD | $46.2K | SEC |
| Mar 14, 2012 | Buy | 4,363 | 1.87 USD | $8.2K | SEC |
| Mar 14, 2012 | Buy | 56,187 | 2.55 USD | $143.3K | SEC |
| Mar 14, 2012 | Buy | 1,601 | 1.89 USD | $3K | SEC |
| Mar 14, 2012 | Buy | 7,484 | 2.99 USD | $22.4K | SEC |
| Mar 14, 2012 | Buy | 32,155 | 2.34 USD | $75.2K | SEC |
| Mar 14, 2012 | Buy | 4,592 | 3.01 USD | $13.8K | SEC |
| Feb 10, 2012 | Buy | 2,865 | 26.62 USD | $76.3K | SEC |
| Feb 10, 2012 | Buy | 999 | 26.17 USD | $26.1K | SEC |
| Feb 10, 2012 | Buy | 9,891 | 26.26 USD | $259.7K | SEC |
| Feb 10, 2012 | Buy | 615 | 26.24 USD | $16.1K | SEC |
| Feb 10, 2012 | Buy | 7,858 | 26.33 USD | $206.9K | SEC |
| Feb 10, 2012 | Buy | 22,251 | 26.18 USD | $582.5K | SEC |
| Feb 10, 2012 | Buy | 4,378 | 26.52 USD | $116.1K | SEC |
| Feb 10, 2012 | Buy | 17,339 | 26.60 USD | $461.2K | SEC |
| Feb 10, 2012 | Buy | 387 | 26.27 USD | $10.2K | SEC |
| Dec 6, 2011 | Buy | 2,867 | 15.39 USD | $44.1K | SEC |
| Dec 6, 2011 | Buy | 11,694 | 15.42 USD | $180.3K | SEC |
| Dec 5, 2011 | Buy | 12,123 | 28.06 USD | $340.2K | SEC |
| Dec 5, 2011 | Buy | 3,940 | 28.03 USD | $110.4K | SEC |
| Dec 5, 2011 | Buy | 1,385 | 28.39 USD | $39.3K | SEC |
| Dec 5, 2011 | Buy | 1,992 | 28.50 USD | $56.8K | SEC |
| Dec 5, 2011 | Buy | 26,537 | 27.33 USD | $725.3K | SEC |
| Nov 23, 2011 | Buy | 1,103 | 12.01 USD | $13.2K | SEC |
| Nov 23, 2011 | Buy | 2,138 | 12.87 USD | $27.5K | SEC |